CureVac NV (CVAC)
2.885
-0.10
(-3.51%)
USD |
NASDAQ |
Dec 20, 16:00
3.10
+0.22
(+7.45%)
After-Hours: 20:00
CureVac Market Cap: 647.22M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioNTech SE | 27.11B |
| Bayer AG | 19.29B |
| Affimed NV | 19.34M |
| InflaRx NV | 132.19M |
| Immatics NV | 832.62M |
Market Cap Related Metrics
| PE Ratio | 5.260 |
| PS Ratio | 1.086 |
| Price to Book Value | 0.7996 |
| Price to Free Cash Flow | 6.075 |
| Price | 2.885 |
| Earnings Yield | 19.01% |
| Operating PE Ratio | 4.397 |
| Normalized PE Ratio | 5.420 |